My Portfolio

Roche Holding AG ROP-CH:Swiss Exchange

*Data is delayed | Exchange | CHF

Last | 5:33 PM CEST

311.60

+1.90 (+0.61%)

Volume

1,045,215

52 week range

243.90 - 374.90

Open309.20
Day High312.30
Day Low306.40
Prev Close309.70
52 Week High374.90
52 Week High Date02/24/26
52 Week Low243.90
52 Week Low Date08/12/25

Latest On Roche Holding AG

UK's biggest drugmakers see profit bump, as pharma grapples with U.S. policiesApril 29, 2026CNBC.com
Novartis CEO warns reality of Trump's drug pricing policy will set in over 'the next 18 months'April 28, 2026CNBC.com
Roche CEO laments Swiss franc strength, continues U.S. investment April 23, 2026CNBC.com
European stocks close higher; Nokia and L'Oreal shares soar on earnings beatsApril 23, 2026CNBC.com
Use options to profit on a catalyst-rich biotech poised to resume a recoveryApril 9, 2026CNBC.com
AstraZeneca stock jumps after surprise lung disease trial winMarch 27, 2026CNBC.com
Zealand CEO hits out at ‘weight loss Olympics’ after disappointing trial resultsMarch 6, 2026CNBC.com
These 4 charts show the scale of Novo Nordisk's woesFebruary 25, 2026CNBC.com
Prices, pipelines and patent cliffs: Inside pharma's big resetFebruary 13, 2026CNBC.com
Drugmakers Roche and Sanofi talk up their pipelines, as earnings fail to exciteJanuary 29, 2026CNBC.com

Key Stats

Market Cap252.163B
Shares Out809.25M
10 Day Average Volume0.85M
Dividend9.80
Dividend Yield3.15%
Beta1.03

Latest On Roche Holding AG

UK's biggest drugmakers see profit bump, as pharma grapples with U.S. policiesApril 29, 2026CNBC.com
Novartis CEO warns reality of Trump's drug pricing policy will set in over 'the next 18 months'April 28, 2026CNBC.com
Roche CEO laments Swiss franc strength, continues U.S. investment April 23, 2026CNBC.com
European stocks close higher; Nokia and L'Oreal shares soar on earnings beatsApril 23, 2026CNBC.com
Use options to profit on a catalyst-rich biotech poised to resume a recoveryApril 9, 2026CNBC.com
AstraZeneca stock jumps after surprise lung disease trial winMarch 27, 2026CNBC.com
Zealand CEO hits out at ‘weight loss Olympics’ after disappointing trial resultsMarch 6, 2026CNBC.com
These 4 charts show the scale of Novo Nordisk's woesFebruary 25, 2026CNBC.com
Prices, pipelines and patent cliffs: Inside pharma's big resetFebruary 13, 2026CNBC.com
Drugmakers Roche and Sanofi talk up their pipelines, as earnings fail to exciteJanuary 29, 2026CNBC.com

KEY STATS

Open309.20
Day High312.30
Day Low306.40
Prev Close309.70
52 Week High374.90
52 Week High Date02/24/26
52 Week Low243.90
52 Week Low Date08/12/25
Market Cap252.163B
Shares Out809.25M
10 Day Average Volume0.85M
Dividend9.80
Dividend Yield3.15%
Beta1.03

RATIOS/PROFITABILITY

EPS (TTM)-
P/E (TTM)-
Fwd P/E (NTM)-
EBITDA (TTM)24.939B
ROE (TTM)39.29%
Revenue (TTM)61.516B
Gross Margin (TTM)73.62%
Net Margin (TTM)22.43%
Debt To Equity (MRQ)93.59%

EVENTS

Earnings Date-
Ex Div Date-
Div Amount-
Split Date-
Split Factor-

Content From Our Affiliates

ASML Stock Crushes European Records as JPMorgan Analyst Warns Investors Are “Behind the Curve”3 Hours AgoTipRanks
Ideaya Biosciences announces IDE892 collaboration with Roche8 Hours AgoTipRanks
FDA issues draft guidance to help accelerated cell, gene therapies for patientsJune 2, 2026TipRanks
Genentech announces FDA acceptance of giredestrant NDA under Priority ReviewJune 2, 2026TipRanks
Deutsche Bank Sticks to Their Hold Rating for Roche Holding AG (RHHVF)May 27, 2026TipRanks

Profile

Roche Holding AG (Roche) is a research-based healthcare company. The Company's operating businesses are organized into two divisions: Pharmaceuticals and Diagnostics. The Pharmaceuticals Division consists of two business segments: Roche Pharmaceuticals and Chugai. The Diagnostics Division consists of four business areas: Diabetes Care, Molecular Diagnostics, Professional Diagnostics and Tissue Diagnostics. The Company develops medicines for various disease areas, including...

Severin Schwan

Non-Executive Chairman of the Board

Thomas Schinecker Ph.D.

Group Chief Executive Officer, Member of the Corporate Executive Committee

Alan Hippe

Chief Financial Officer, Member of the Corporate Executive Committee

Wafaa Mamilli

Chief Digital and Technology Officer, Member of the Enlarged Corporate Executive Committee

Claudia Boeckstiegel

Member of the Enlarged Corporate Executive Committee, General Counsel

Address

Grenzacherstr. 124

Basel

4058

Switzerland

https://www.roche.com/